LncRNA FIRRE drives gastric cancer progression via ZFP64-mediated TUBB3 promoter activation
Cancer Letters · 2025
DOI: 10.1016/j.canlet.2024.217398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Jingwen Yuan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery I Section, Renmin Hospital of Wuhan University, Wuhan, 430060, China; Colorectal Surgery Department, Changhai …. Hauptthemen laut MEDLINE: Stomach Neoplasms, Promoter Regions, Genetic, RNA, Long Noncoding, Transcription Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Hubei Province Natural Science Foundation, Wuhan University Renmin Hospital, Wuhan University.
Abstract (Originalsprache)
Gastric cancer is a common global malignancy that requires detailed study of its development mechanisms. Although LncRNA FIRRE is known to play a crucial role in the progression and treatment resistance of several cancers, its effect on gastric cancer is not well understood. This study confirms the impact of FIRRE on the malignant behavior of gastric cancer. Using RNA-sequencing, dual luciferase reporter assay, RIP and CHIP, we identified transcription factors and target genes linked to FIRRE. Elevated FIRRE expression in gastric cancer correlates with worse patient prognosis and promotes gastric cancer proliferation, migration, and invasion both in vitro and in vivo. FIRRE regulates the TUBB3 gene, facilitating gastric cancer progression by activating the TUBB3 promoter in vitro. ZFP64 is the transcription factor for TUBB3, activating its promoter and binding specifically with FIRRE. Reducing ZFP64 disrupts FIRRE's positive regulation of TUBB3 in vitro and in vivo. This study shows FIRRE promotes gastric cancer progression by binding to ZFP64 and activating the TUBB3 promoter.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery I Section, Renmin Hospital of Wuhan University, Wuhan, 430060, China; Colorectal Surgery Department, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
- Department of Gastrointestinal Surgery I Section, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
- Hubei Province Key Laboratory of Allergy and Immunology, Department of Medical Parasitology, School of Basic Medical Sciences, Wuhan University, Wuhan, Hubei, China.
- Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
- Hubei Province Key Laboratory of Allergy and Immunology, Department of Medical Parasitology, School of Basic Medical Sciences, Wuhan University, Wuhan, Hubei, China. Electronic address: ruizhou@whu.edu.cn.
- Department of Gastrointestinal Surgery I Section, Renmin Hospital of Wuhan University, Wuhan, 430060, China. Electronic address: qiangtong@whu.edu.cn.
Förderung
- Hubei Province Natural Science Foundation
- Wuhan University Renmin Hospital
- Wuhan University
- National Natural Science Foundation of China
Zitieren
APA
Yuan, J., Lu, J., Zhu, J., Chen, F., Zeng, Z., Yan, J., Li, Q., Zhou, R., & Tong, Q. (2025). LncRNA FIRRE drives gastric cancer progression via ZFP64-mediated TUBB3 promoter activation. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217398
Vancouver
Yuan J, Lu J, Zhu J, Chen F, Zeng Z, Yan J, et al. LncRNA FIRRE drives gastric cancer progression via ZFP64-mediated TUBB3 promoter activation. Cancer Letters. 2025. doi:10.1016/j.canlet.2024.217398
BibTeX
@article{Yuan2025,
author = {Yuan, Jingwen and Lu, Jiatong and Zhu, Jie and Chen, Fangfang and Zeng, Zhi and Yan, Junfeng and Li, Qiang and Zhou, Rui and Tong, Qiang},
title = {LncRNA FIRRE drives gastric cancer progression via ZFP64-mediated TUBB3 promoter activation},
journal = {Cancer Letters},
year = {2025},
doi = {10.1016/j.canlet.2024.217398}
}
EUVIMED